FAM57A expression markedly related to age (p=0.004), gender (p=0.033), pathologic tumor grade (p=2.268e-04), clinical stage (p=0.004), and T stage (p=5.742e-04) based on the TCGA database (Figure 4). This evidence concerns the gene TLCD3A and neoplasm.